Contact Information: For more information, contact EnviroLogix Inc. Bruce S. Ferguson President 207-797-0300
EnviroLogix Announces Receipt of DNA Development Award
| Source: EnviroLogix Inc.
PORTLAND, ME--(Marketwire - July 1, 2009) - Earlier in June, EnviroLogix was one of five
Maine companies to receive a Maine Technology Institute "Development
Award." Fourteen companies applied for competitive Development funds. The
award, made by MTI's Board of Directors, provides for up to $500,000 in
funding to selected recipients and requires at least a 1:1 dollar match by
the winning company. EnviroLogix applied for and was awarded $499,727 and
will match with $499,805.
Supplemented by this award, EnviroLogix will continue to improve and
optimize isothermal amplification methods, exclusively licensed from Ionian
Technologies Inc. (San Diego, CA) for agricultural, plant pathogen and
veterinary markets. The NEAR (Nicking Enzyme Amplification Reaction) Assay
permits the amplification of DNA and RNA in approximately 5-7 minutes, with
sensitivity and specificity equal to or better than PCR methods. The
amplification products can be detected by a variety of standard methods,
including LC-MS, fluorescence detection using widely available
thermocyclers or a low cost fluorimeter, or lateral flow strips compatible
with point-of-testing devices.
Funding by the Maine Technology Institute will be directed at the rapid
detection of selected genes or gene segments specific to Clavibacter
michiganensis subsp. michiganensis (Cmm), a pathogen affecting tomato seed
and financially crippling to the tomato industry and commercial seed
suppliers. A rapid, sensitive and specific assay for Cmm would be welcomed
by these markets. In combination with NEAR technology, assays will be
developed using Immunomagnetic Separation (IMS), fluorescence-based
molecular beacons, and lateral flow methods.
Founded in 1996, EnviroLogix also develops, manufactures, and markets
immunoassays for the detection of GMOs, mycotoxins, plant pathogens, algal
toxins, molds, and pesticides. The Company encourages inquiries about
Custom Assay Development for both immunoassay and DNA platforms.